Citations (35)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (12)
Gerhard Klausmann, Irene Hramiak, Marianne Qvist, Kristian Handberg Mikkelsen & Xiaohui Guo. (2013) Evaluation of preference for a novel durable insulin pen with memory function among patients with diabetes and health care professionals. Patient Preference and Adherence 7, pages 285-292.
Read now
Read now
David Oyer, Marcus Niemeyer & Alan Moses. (2012) Empowering People with Diabetes: Improving Perceptions and Outcomes with Technical Advances in Insulin Pens. Postgraduate Medicine 124:5, pages 110-120.
Read now
Read now
Xiaohui Guo, Bärbel Sommavilla, Grace Vanterpool, Marianne Qvist, Matthias Bethien & Søren Kruse Lilleøre. (2012) Evaluation of a new durable insulin pen with memory function among people with diabetes and healthcare professionals. Expert Opinion on Drug Delivery 9:4, pages 355-366.
Read now
Read now
Birtha Hansen & Irina Matytsina. (2011) Insulin administration: selecting the appropriate needle and individualizing the injection technique. Expert Opinion on Drug Delivery 8:10, pages 1395-1406.
Read now
Read now
T. Bailey, J. Thurman, M. Niemeyer & G. Schmeisl. (2011) Usability and preference evaluation of a prefilled insulin pen with a novel injection mechanism by people with diabetes and healthcare professionals. Current Medical Research and Opinion 27:10, pages 2043-2052.
Read now
Read now
Estella M Davis, Emily L Sexson, Mikayla L Spangler & Pamela A Foral. (2010) An evaluation of prefilled insulin pens: a focus on the Next Generation FlexPen®. Medical Devices: Evidence and Research 3, pages 41-50.
Read now
Read now
L. Niskanen. (2010) A clinical and health economic review of a prefilled insulin pen. Current Medical Research and Opinion 26:10, pages 2431-2439.
Read now
Read now
Michael Opincar & Debra Ignaut. (2009) Comment and reply on: Evaluation of injection force of three insulin delivery pens. Expert Opinion on Pharmacotherapy 10:14, pages 2391-2392.
Read now
Read now
T Asakura, H Seino, M Kageyama & N Yohkoh. (2009) Evaluation of injection force of three insulin delivery pens. Expert Opinion on Pharmacotherapy 10:9, pages 1389-1393.
Read now
Read now
Andreas Pfützner. (2009) FlexPen® for the delivery of insulin: accuracy, injection force and patient preference. Expert Review of Medical Devices 6:2, pages 115-123.
Read now
Read now
Athena Philis-Tsimikas. (2008) Tolerability, safety and adherence to treatment with insulin detemir injection in the treatment of type 2 diabetes. Patient Preference and Adherence 2, pages 323-332.
Read now
Read now
A Pfützner, T Asakura, B Sommavilla & WC Lee. (2008) Insulin delivery with FlexPen®: dose accuracy, patient preference and adherence. Expert Opinion on Drug Delivery 5:8, pages 915-925.
Read now
Read now
Articles from other publishers (23)
Michael K. Danquah & Jaison Jeevanandam. 2022. Emerging Nanomedicines for Diabetes Mellitus Theranostics. Emerging Nanomedicines for Diabetes Mellitus Theranostics
1
31
.
Arvind GuptaSanjeev PhatakY. Sadashiv RaoJayanthy Ramesh & Debmalya Sanyal. (2020) Consensus on Choice of Insulin Pen Devices in Routine Clinical Practice in India. Diabetes Technology & Therapeutics 22:10, pages 777-786.
Crossref
Crossref
Hamdi Ellouzi, Hela Ltifi & Mounir Ben Ayed. (2017) Multi-agent modelling of decision support systems based on visual data mining. Multiagent and Grid Systems 13:1, pages 31-45.
Crossref
Crossref
Colin H. Ridyard, Dalia M. M. Dawoud, Lorna V. Tuersley & Dyfrig A. Hughes. (2016) A Systematic Review of Patients’ Perspectives on the Subcutaneous Route of Medication Administration. The Patient - Patient-Centered Outcomes Research 9:4, pages 281-292.
Crossref
Crossref
Danny D Meetoo. (2016) Insulin: An evolving paradigm in diabetes management. Practice Nursing 27:Sup3, pages 11-16.
Crossref
Crossref
Steve Chasin & Linda Morrissey. (2013) Pen colors facilitate the differentiation of SoloSTAR® insulin pens by users with normal and impaired color vision. Diabetes Management 3:1, pages 25-30.
Crossref
Crossref
Danny D Meetoo. (2013) Insulin: an evolving paradigm in diabetes management. British Journal of Healthcare Management 19:Sup1, pages 8-15.
Crossref
Crossref
Andreas Liebl, Vinay Prusty, Paul Valensi, Ryuzo Kawamori, Jens Sandahl Christiansen, Andrew J. Palmer, Per Balschmidt, Robert Ligthelm & Viswanathan Mohan. (2012) Ten Years of Experience with Biphasic Insulin Aspart 30. Drugs 72:11, pages 1495-1520.
Crossref
Crossref
Danny MeetooGillian McAllister, Adele West & Mandy Turnbull. (2012) In pursuit of excellence in diabetes care: trends in insulin delivery. British Journal of Nursing 21:10, pages 588-595.
Crossref
Crossref
Geralyn R. Spollett. (2012) Improved Disposable Insulin Pen Devices Provide an Alternative to Vials and Syringes for Insulin Administration. Diabetes Spectrum 25:2, pages 117-122.
Crossref
Crossref
Elizabeth Arnold, Anne Bruton, Maggie Donovan-Hall, Angela Fenwick, Bridget Dibb & Elizabeth Walker. (2011) Ambulatory oxygen: why do COPD patients not use their portable systems as prescribed? A qualitative study. BMC Pulmonary Medicine 11:1.
Crossref
Crossref
Hans HemmingsenMarcus NiemeyerMarianne Rye HansenDitlef BucherNiels Bjerrum Thomsen. (2011) A Prefilled Insulin Pen with a Novel Injection Mechanism and a Lower Injection Force than Other Prefilled Insulin Pens. Diabetes Technology & Therapeutics 13:12, pages 1207-1211.
Crossref
Crossref
Barbara J. AndersonMaria J. Redondo. (2011) What Can We Learn from Patient-Reported Outcomes of Insulin Pen Devices?. Journal of Diabetes Science and Technology 5:6, pages 1563-1571.
Crossref
Crossref
Paul HofmanSøren Kruse Lilleøre & Gitte Ter-Borch. (2011) Needle with a Novel Attachment versus Conventional Screw-Thread Needles: A Preference and Ease-of-Use Test among Children and Adolescents with Diabetes. Journal of Diabetes Science and Technology 5:6, pages 1480-1487.
Crossref
Crossref
Jakob Oest Wielandt, Marcus Niemeyer, Marianne Rye Hansen, Ditlef Bucher & Niels Bjerrum Thomsen. (2011) FlexTouch: A Prefilled Insulin Pen with a Novel Injection Mechanism with Consistent High Accuracy at Low- (1 U), Medium- (40 U), and High- (80 U) Dose Settings. Journal of Diabetes Science and Technology 5:5, pages 1195-1199.
Crossref
Crossref
Melissa L Magwire. (2011) Addressing Barriers to Insulin Therapy: The Role of Insulin Pens. American Journal of Therapeutics 18:5, pages 392-402.
Crossref
Crossref
Birtha HansenSøren K. LilleøreGitte Ter-Borch. (2011) Needle with a Novel Attachment Versus Conventional Screw-Thread Needles: A Preference and Usability Test Among Adults with Diabetes and Impaired Manual Dexterity. Diabetes Technology & Therapeutics 13:5, pages 579-585.
Crossref
Crossref
Andreas Pfützner & Bärbel Sommavilla. (2010) Comment on Comparative Device Assessments. The Diabetes Educator 36:5, pages 710-712.
Crossref
Crossref
Teresa L. Pearson. (2010) Practical Aspects of Insulin Pen Devices. Journal of Diabetes Science and Technology 4:3, pages 522-531.
Crossref
Crossref
Ann S. Williams & Patrick A. Schnarrenberger. (2010) A Comparison of Dosing Accuracy: Visually Impaired and Sighted People Using Insulin Pens. Journal of Diabetes Science and Technology 4:3, pages 514-521.
Crossref
Crossref
Janakie Singham, Erica D. Greanya, Kirby Lau, Siegfried R. Erb, Nilu Partovi & Eric M. Yoshida. (2010) Efficacy of maintenance subcutaneous hepatitis B immune globulin (HBIG) post-transplant for prophylaxis against hepatitis B recurrence†. Annals of Hepatology 9:2, pages 166-171.
Crossref
Crossref
Morten DonsmarkLars HeroldCarsten Mølgård Kristensen. (2009)
A Comparison of Injection Force and Dosage Scale Size Between NovoPen
®
3 and NovoPen
®
4
. Diabetes Technology & Therapeutics 11:9, pages 581-585.
Crossref
Crossref
Paul GrantUmesh Dashora. (2009) High-mix analogue insulins: do they have a therapeutic role?. The British Journal of Diabetes & Vascular Disease 9:4, pages 166-170.
Crossref
Crossref